Inflection Pharma Consulting ApS: Financial statements 2020
CVR: 39685507
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
Inflection Pharma Consulting ApS (CVR 39685507) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 47,149 and a net result of DKK 36,237 compared with DKK 27,608 the year before. That is an increase of 29.2% compared with the year before. Equity in the 2020 report amounted to DKK 118,088. The solvency ratio was 83.8%.
- Gross Profit
- DKK 47,149
- Profit/Loss
- DKK 36,237
- Equity
- DKK 118,088
- Total Assets
- DKK 140,872
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | 47 t. | 36 t. | 118 t. | - |
| 2019 | - | 36 t. | 28 t. | 82 t. | - |
Official annual report
How creditworthy is Inflection Pharma Consulting ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
Inflection Pharma Consulting ApS has published its annual report for 2019. Gross profit came to DKK 36,496, and the net result was DKK 27,608.
About Inflection Pharma Consulting ApS
Inflection Pharma Consulting ApS was a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2018. The company has been dissolved on 1 November 2022. The company was registered under the industry Anden teknisk rådgivning. In 2021, the company reported a gross profit of DKK -1,832 and a net result of DKK -11,890 compared with DKK 36,237 the year before. Equity in the 2021 report amounted to DKK 93,827.